title: Imbalanced protein expression patterns of anabolic, catabolic, anti-catabolic and inflammatory cytokines in degenerative cervical disc cells: new indications for gene therapeutic treatments of cervical disc diseases.
abstract: Degenerative disc disease (DDD) of the cervical spine is common after middle age and can cause loss of disc height with painful nerve impingement, bone and joint inflammation. Despite the clinical importance of these problems, in current publications the pathology of cervical disc degeneration has been studied merely from a morphologic view point using magnetic resonance imaging (MRI), without addressing the issue of biological treatment approaches. So far a wide range of endogenously expressed bioactive factors in degenerative cervical disc cells has not yet been investigated, despite its importance for gene therapeutic approaches. Although degenerative lumbar disc cells have been targeted by different biological treatment approaches, the quantities of disc cells and the concentrations of gene therapeutic factors used in animal models differ extremely. These indicate lack of experimentally acquired data regarding disc cell proliferation and levels of target proteins. Therefore, we analysed proliferation and endogenous expression levels of anabolic, catabolic, ant-catabolic, inflammatory cytokines and matrix proteins of degenerative cervical disc cells in three-dimensional cultures. Preoperative MRI grading of cervical discs was used, then grade III and IV nucleus pulposus (NP) tissues were isolated from 15 patients, operated due to cervical disc herniation. NP cells were cultured for four weeks with low-glucose in collagen I scaffold. Their proliferation rates were analysed using 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide. Their protein expression levels of 28 therapeutic targets were analysed using enzyme-linked immunosorbent assay. During progressive grades of degeneration NP cell proliferation rates were similar. Significantly decreased aggrecan and collagen II expressions (P<0.0001) were accompanied by accumulations of selective catabolic and inflammatory cytokines (disintegrin and metalloproteinase with thrombospondin motifs 4 and 5, matrix metalloproteinase 3, interleukin-1β, interleukin-1 receptor) combined with low expression of anti-catabolic factor (metalloproteinase inhibitor 3) (P<0.0001). This study might contribute to inhibit inflammatory catabolism of cervical discs.
authors.affiliation: Department of Neurosurgery, Innsbruck Medical University, Innsbruck, Tirol, Austria.
authors.forename: Demissew S
authors.initials: DS
authors.lastname: Mern
authors.affiliation: Department of Neurosurgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany.
authors.forename: Anja
authors.initials: A
authors.lastname: Beierfuβ
authors.affiliation: Department of Neurosurgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany.
authors.forename: Johann
authors.initials: J
authors.lastname: Fontana
authors.affiliation: Department of Neurosurgery, Innsbruck Medical University, Innsbruck, Tirol, Austria.
authors.forename: Claudius
authors.initials: C
authors.lastname: Thomé
authors.affiliation: Department of Neurosurgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany.
authors.forename: Aldemar A
authors.initials: AA
authors.lastname: Hegewald
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000235:genetics; D002478:Cells, Cultured; D019483:Disintegrins / Q000096:biosynthesis*; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D006801:Humans; D007249:Inflammation / Q000235:genetics / Q000473:pathology / Q000628:therapy; D053583:Interleukin-1beta / Q000096:biosynthesis*; D055959:Intervertebral Disc Degeneration / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D008159:Lumbar Vertebrae / Q000378:metabolism / Q000473:pathology; D064235:Matrilin Proteins / Q000096:biosynthesis; D019278:Matrix Metalloproteinase 3 / Q000096:biosynthesis*; D019699:Thrombospondins / Q000096:biosynthesis; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000096:biosynthesis
chemical_list: D019483:Disintegrins; D053583:Interleukin-1beta; D064235:Matrilin Proteins; C088390:TIMP3 protein, human; D019699:Thrombospondins; D019717:Tissue Inhibitor of Metalloproteinase-3; D019278:Matrix Metalloproteinase 3